Dumalan, Amirah Kate S.
HRN: 20-91-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/22/2022
11/28/2022
ORAL
2ml
Q12Hrs
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes